Canterbury DHB

Context

Acquired CMV Infection - Treatment

For general information about CMV, see UpToDate website.

In This Section

Clinical Features

Diagnosis

Treatment

Clinical Features

These are extremely variable.

Diagnosis

The diagnostic test currently recommended is Q-PCR for CMV DNA on plasma and white blood cells. The results are now reported in International Units per litre (IU/L).

Take 5 mL blood into EDTA (mauve top) tube. This will detect CMV viral DNA, and give a measure of the viral load present. Repeat testing can be used to monitor progression or the effectiveness of treatment.

Treatment

See:

Note: Oral valganciclovir is also available. For more information, see the valganciclovir Data Sheets on Medsafe.

Foscarnet

Foscarnet may be used in place of ganciclovir when ganciclovir marrow suppression is present:

The major complication of foscarnet is electrolyte disturbance which needs to be checked daily, including magnesium and phosphate.

For more information about foscarnet, refer to the Data Sheets on Medsafe.

About this Canterbury DHB document (5030):

Document Owner:

Ruth Spearing and Sarah Metcalfe (see Who's Who)

Issue Date:

November 2016

Next Review:

November 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5030